Orasis Pharmaceuticals Ltd.
Quick facts
Phase 3 pipeline
- CSF-1 · Immunology
CSF-1 is a recombinant human colony-stimulating factor 1 that promotes the growth and differentiation of myeloid progenitor cells.
Phase 2 pipeline
- CSF-1 Component #1 · Immunology
CSF-1 Component #1 is a protein that modulates the activity of the colony-stimulating factor 1 receptor. - CSF-1 Component #2 · Immunology
CSF-1 Component #2 is a protein that modulates immune cell function.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Orasis Pharmaceuticals Ltd.
What is Orasis Pharmaceuticals Ltd.'s pipeline?
Orasis Pharmaceuticals Ltd. has 1 drugs in Phase 3, 2 in Phase 2, 0 in Phase 1. Late-stage candidates include CSF-1.
Related
- Sector hub: All tracked pharma companies